Humanin
Investigational mitochondrial-derived peptide (cytoprotection research) · Pre-filled pen
Humanin is a small mitochondrial-derived peptide studied for cytoprotective signalling that may help cells resist oxidative and metabolic stress. In laboratory models it has been associated with survival and neuroprotective pathways, and in humans it appears mostly as a biomarker whose levels change with age. Direct therapeutic use in people remains investigational and unproven.
Studied use areas
- Mitochondrial cytoprotection signalling (research interest)
- Cellular stress-resistance pathways
- Neuroprotection and cognitive-ageing markers (investigational)
- Mitochondrial-efficiency and energy-stability endpoints (exploratory)
Safety & status
- Investigational peptide with no established human safety profile; physician supervision required
- Not approved as a medicine by EMA or MHRA
- Neurological or cognitive concerns need proper medical evaluation rather than self-directed peptide use
⚕ Clinical note: This is educational information only and not medical advice. Humanin is investigational; any use should be individualised and determined by a treating physician under appropriate supervision.
Evidence: Grade D — investigational; predominantly preclinical and biomarker-association data, with no controlled human trials. · References: Peer-reviewed mitochondrial-derived peptide literature; Cellular stress-resistance and ageing-biology reviews; EMA/MHRA guidance on investigational substances




